Cite

HARVARD Citation

    Paris, K. et al. (2019). Tolerability of subcutaneous immunoglobulin 20%, Ig20Gly, in pediatric patients with primary immunodeficiencies. Immunotherapy. pp. 397-406. [Online]. 
  
Back to record